Articles tagged "Infection"

2019 American Transplant Congress
ABMR In Low-single Dose Thymoglobulin Induction Protocol In Renal Transplant Recepients From A Tertiary Care Centre In A Developing Country
R. Parthasarathy¹, M. Mohammed¹, P. Koshy², I. Pradeep², M. Mathew¹, G. Abraham¹
¹Nephrology, Madras Medical Mission, Chennai, India, ²Pathology, Madras Medical Mission, Chennai, India
*Purpose: Fool proof induction therapy in low sensitized patients is still elusive. There is a thin line between over immunosuppression and infection . Conventional rabbit…
2019 American Transplant Congress
The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults
J. Garcia-Diaz¹, M. Kerkelis², T. Shah³, M. Tucker⁴, M. Gastanaduy⁵, J. Woo¹, M. Ponder¹, M. Malinis⁶, M. Malinis⁶
¹Infectious Diseases, Ochsner Medical Center, New Orleans, LA, ²University of Queensland/Ochsner Clinical School, New Orleans, LA, ³Internal Medicine, St. Joseph Hospital, Denver, CO, ⁴Internal Medicine, Yale School of Medicine, New Haven, CT, ⁵Center for Outcomes and Health Services Research, Ochsner Medical Center, New Orleans, LA, ⁶Infectious Diseases, Yale School of Medicine, New Haven, CT
*Purpose: Solid organ transplantation is being increasingly offered to older patients with concurrent chronic medical conditions such as cardiovascular, cerebrovascular, and renal disease. Risk of…
2019 American Transplant Congress
Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients
G. Huang¹, X. Chen¹, S. Yang², W. Chen², P. Chen³, X. Hou⁴, T. Jiang⁵, H. Liu⁵, X. Li⁵, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ³Department of clinical laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ⁴Guangzhou KingMed Center for Clinical Laboratory Co.,Ltd., Guangzhou, China, ⁵Research and Development, AlloDx Biotech Co.Ltd., Suzhou, China
*Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. Elevated levels of donor-derived cell-free DNA (dd-cfDNA) in the…
2019 American Transplant Congress
Infectious Complications in Kidney Transplant Recipients Age 65 and Older
L. E. Liriano-Ward¹, M. Barbachan e Silva², Y. Azzi¹, M. Ajaimy¹, A. Cambell¹, J. Graham¹, J. Rocca¹, C. Pynadath¹, G. Nair¹, O. Andacoglu¹, S. Greenstein¹, P. Ó Broin², E. Akalin¹
¹Transplant, Einstein/Montefiore Medical Center, Bronx, NY, ²School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland
*Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…
2019 American Transplant Congress
Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk
C. Masset¹, J. Boucquemont², V. Garrigue³, M. Ladrière⁴, F. Buron⁵, E. Cassuto⁶, Y. Foucher², J. Dantal¹
¹University Hospital of Nantes, Nantes, France, ²University of Nantes, Nantes, France, ³University Hospital of Montpellier, Montpellier, France, ⁴University Hospital of Nancy, Nancy, France, ⁵University Hospital of Lyon, Lyon, France, ⁶University Hospital of Nice, Nice, France
*Purpose: Thymoglobulin (ATG) and Basiliximab (BSX) lead to similar rejection rates in low immunological risk patients. ATG seems to be associated with infectious and malignancy…
2019 American Transplant Congress
Effect of Influenza Vaccine in Patients with Kidney Transplant during 2017/2018
K. Tsujimura¹, M. Ota¹, H. Ishida², K. Tanabe²
¹Surgery, Tomishiro Central Hospital, Okinawa, Japan, ²Urology, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: This study aimed to evaluate the effect of influenza vaccine in kidney transplant recipients during the 2017/2018.*Methods: We retrospectively assessed 136 patients who underwent…
2019 American Transplant Congress
Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study
N. Perrottet¹, D. Golshayan², O. Manuel², V. Aubert², M. Koller³, K. Hadaya⁴, L. Bühler⁴, T. Mueller⁵, U. Huynh-Do⁶, S. Dahdal⁶, I. Binet⁷, M. Dickenmann³, S. Schaub³, J. Steiger³, M. Pascual², M. Fernández-Ruiz²
¹Pharmacy, CHUV, Lausanne, Switzerland, ²CHUV, Lausanne, Switzerland, ³USB, Basel, Switzerland, ⁴HUG, Geneva, Switzerland, ⁵USZ, Zurich, Switzerland, ⁶Inselspital, Bern, Switzerland, ⁷KSSG, St. Gallen, Switzerland
*Purpose: Multimodal therapeutic strategies used to treat acute antibody-mediated rejection (AMR) could enhance the risk of infection. However, data in this context are scarce.*Methods: We…
2019 American Transplant Congress
Assessment of Serum Tim3 and Gal9 Levels in Predicting the Risk of Infection after Kidney Transplantation
Y. Shi¹, y. li², Y. Li², L. Yan², J. Tang², X. Wu², Y. Bai², Y. An², B. Dai², C. Yang², L. Wang²
¹Department of Nephrology, West China Hospital, Chengdu, China, ²Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Infection remains a major cause of morbidity and mortality after kidney transplantation (KT). However, reliable biomarkers to predict the occurrence of post-transplant infection are…
2019 American Transplant Congress
Gut Microbiome And Acute Rejection After Kidney Transplantation
H. Cho¹, Y. Yang¹, J. Kim², J. Moon², J. Jeong², J. Park³, M. Kwak⁴, B. Kim⁴, D. Kim², J. Lee⁵, B. Kim⁶, Y. Kim², H. Lee²
¹Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea, Republic of, ²Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ³Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea, Republic of, ⁴ChunLab Inc., Seoul, Korea, Republic of, ⁵Internal Medicine, Seoul National University, Boramae Hospital, Seoul, Korea, Republic of, ⁶Hallym University, Chuncheon, Korea, Republic of
*Purpose: Acute rejection (AR) is a common complication in kidney transplantation (KT) and associated with reduced patient-graft survival. Recent studies have shown that the gut…
2019 American Transplant Congress
Treatment of Pseudomonas Infection with Beta-Lactams Including Ceftolozane-Tazobactam in Solid Organ Transplant Recipients
M. Henry¹, J. Puvvula², J. John Schoen¹, L. Puzniak³, J. Raddatz⁴, T. Van Schooneveld², S. Bergman¹
¹Nebraska Medicine, Omaha, NE, ²University of Nebraska Medical Center, Omaha, NE, ³Merck & Co., Inc, Kenilworth, NJ, ⁴Merck & Co., Inc, Kenilworth, NJ, NJ
*Purpose: Ceftolozane/Tazobactam (CT) is a potent anti-pseudomonal agent with broad gram-negative activity. Our academic medical center recommends the use of CT for patients with a…